The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
Russian Healthcare Minister Veronika Skvortsova says there won’t be restrictions for Russians, health is the priority.
BioNevia LLC and its development partner, NeuroMax Ltd, today announced the completion of enrollment in NM-ARI-231, a Phase 2b randomized, double-blind, placebo-controlled twelve month, chronic efficacy and safety study of BNV-222 (diepalrestat) in adult subjects with diabetic peripheral neuropathy. Four hundred (400) subjects were enrolled in 27 sites in Russia. The ongoing Phase 2b clinical trial evaluates efficacy on motor nerve conduction velocity, clinical outcomes, and visual acuity.
The Russian government has decided to postpone the introduction of a controversial scheme for the compulsory licensing of drugs imported into Russia, as proposed by some local drugmakers.
Global dermatology market set to grow from $20 billion in 2015 to $33.7 billion by 2022, at a compound annual growth rate of 7.7%. This strong growth will be driven by a robust late-stage pipeline, including valuable targeted therapies such as dupilumab and ixekizumab, says analyst
1 - 5 из 837
The Russian government has designed a new package of measures aimed at providing support to domestic drugmakers as well as global majors, operating their plants within the country.
Начало | Пред. |
programmer of electronic software products